Open Orphan (ORPH) Notice of AGM September 12, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, announces that the Company’s Annual General Meeting will be held on 2 October 2019 at 12 noon at Jeffreys Henry LLP, Finsgate, 5-7 Cranwood Street, London EC1V 9EE. A copy of the notice of Annual General Meeting has been sent to shareholders and is available from the Company’s website. Enquiries: Open Orphan Plc Tel: +353 (0)1 644 0007 Cathal Friel, Chief Executive Officer Arden…

Open Orphan (ORPH) sells its remaining shareholding in Integumen plc July 12, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, announces that it has now sold its remaining shareholding in Integumen plc following its disposal of 30,071,428 ordinary shares. The total proceeds of the sale are £566,846. This completes the process begun with the divestment of Innovenn UK limited to Integumen plc in November 2016. The disposal allows the Company to focus all its resources on its core strategy of creating a focused orphan drug platform…

Open Orphan (ORPH) Notice of AGM September 12, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan (ORPH) sells its remaining shareholding in Integumen plc July 12, 2019 – Posted in: Open Orphan (ORPH)

Address

Contact

Social

LEGAL